MicroRNA-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor γ dependent Hsp90-eNOS signaling and nitric oxide production

Biochemical and Biophysical Research Communications

Volumn 460, Issue 2, 2015, Pages 469-475

  Bi, Rui ^a   Bao, Chunrong ^a   Jiang, Lianyong ^a   Liu, Hao ^a   Yang, Yang ^a   Mei, Ju ^a   Ding, Fangbao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Endothelial nitric oxide synthase; miR 27b; NO; PPAR ; Pulmonary artery hypertension

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 90; MICRORNA; MIRN27 MICRORNA, RAT; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL; BIOSYNTHESIS; CELL CULTURE; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

ANIMALS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HSP90 HEAT-SHOCK PROTEINS; HUMANS; HYPERTENSION, PULMONARY; MALE; MICRORNAS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84937762662     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.03.057     Document Type: Article

References (34)

1. R.M. Tuder, S.L. Archer, P. Dorfmuller, S.C. Erzurum, C. Guignabert, E. Michelakis, M. Rabinovitch, R. Schermuly, K.R. Stenmark, and N.W. Morrell Relevant issues in the pathology and pathobiology of pulmonary hypertension J. Am. Coll. Cardiol. 62 2013 D4 D12
2. G. Hansmann, V.A. de Jesus Perez, T.P. Alastalo, C.M. Alvira, C. Guignabert, J.M. Bekker, S. Schellong, T. Urashima, L. Wang, N.W. Morrell, and M. Rabinovitch An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension J. Clin. Invest 118 2008 1846 1857
3. R.T. Schermuly, H.A. Ghofrani, M.R. Wilkins, and F. Grimminger Mechanisms of disease: pulmonary arterial hypertension Nat. Rev. Cardiol. 8 2011 443 455
4. D. Zhang, G. Wang, D. Han, Y. Zhang, J. Xu, J. Lu, S. Li, X. Xie, L. Liu, L. Dong, and M. Li Activation of PPAR-gamma ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats Life Sci. 98 2013 39 43
5. N. Marx, H. Duez, J.C. Fruchart, and B. Staels Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells Circ. Res. 94 2004 1168 1178
6. J.T. Kielstein, S.M. Bode-Boger, G. Hesse, J. Martens-Lobenhoffer, A. Takacs, D. Fliser, and M.M. Hoeper Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension Arterioscler. Thromb. Vasc. Biol. 25 2005 1414 1418
7. F. Martin-Nizard, C. Furman, P. Delerive, A. Kandoussi, J.C. Fruchart, B. Staels, and P. Duriez Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cells J. Cardiovasc Pharmacol. 40 2002 822 831
8. P. Balakumar, and S. Kathuria Submaximal PPARgamma activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders Br. J. Pharmacol. 166 2012 1981 1992
9. D.H. Cho, Y.J. Choi, S.A. Jo, and I. Jo Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways J. Biol. Chem. 279 2004 2499 2506
10. C. Gensch, Y.P. Clever, C. Werner, M. Hanhoun, M. Bohm, and U. Laufs The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells Atherosclerosis 192 2007 67 74
11. G. Garcia-Cardena, R. Fan, V. Shah, R. Sorrentino, G. Cirino, A. Papapetropoulos, and W.C. Sessa Dynamic activation of endothelial nitric oxide synthase by Hsp90 Nature 392 1998 821 824
12. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
13. P. Caruso, M.R. MacLean, R. Khanin, J. McClure, E. Soon, M. Southgate, R.A. MacDonald, J.A. Greig, K.E. Robertson, R. Masson, L. Denby, Y. Dempsie, L. Long, N.W. Morrell, and A.H. Baker Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline Arterioscler. Thromb. Vasc. Biol. 30 2010 716 723
14. D. Biyashev, D. Veliceasa, J. Topczewski, J.M. Topczewska, I. Mizgirev, E. Vinokour, A.L. Reddi, J.D. Licht, S.Y. Revskoy, and O.V. Volpert miR-27b controls venous specification and tip cell fate Blood 119 2012 2679 2687
15. C. Urbich, D. Kaluza, T. Fromel, A. Knau, K. Bennewitz, R.A. Boon, A. Bonauer, C. Doebele, J.N. Boeckel, E. Hergenreider, A.M. Zeiher, J. Kroll, I. Fleming, and S. Dimmeler MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A Blood 119 2012 1607 1616
16. L. Jin, O. Wessely, E.G. Marcusson, C. Ivan, G.A. Calin, and S.K. Alahari Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-alpha in breast cancer Cancer Res. 73 2013 2884 2896
17. J. Ye, X. Wu, D. Wu, P. Wu, C. Ni, Z. Zhang, Z. Chen, F. Qiu, J. Xu, and J. Huang miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer PLoS One 8 2013 e60687
18. M. Karbiener, C. Fischer, S. Nowitsch, P. Opriessnig, C. Papak, G. Ailhaud, C. Dani, E.Z. Amri, and M. Scheideler microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma Biochem. Biophys. Res. Commun. 390 2009 247 251
19. J.J. Lee, A. Drakaki, D. Iliopoulos, and K. Struhl MiR-27b targets PPARgamma to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells Oncogene 31 2012 3818 3825
20. X. Chang, Y. Sun, S. Han, W. Zhu, H. Zhang, and S. Lian MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1 Biochem. Biophys. Res. Commun. 456 2015 361 366
21. M.P. Gupta, M.D. Ober, C. Patterson, M. Al-Hassani, V. Natarajan, and C.M. Hart Nitric oxide attenuates H(2)O(2)-induced endothelial barrier dysfunction: mechanisms of protection Am. J. Physiol. Lung Cell. Mol. Physiol. 280 2001 L116 L126
22. A.T. Gonon, A. Bulhak, F. Labruto, P.O. Sjoquist, and J. Pernow Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide Basic Res. Cardiol. 102 2007 80 89
23. N. Kobayashi, T. Ohno, K. Yoshida, H. Fukushima, Y. Mamada, M. Nomura, H. Hirata, Y. Machida, M. Shinoda, N. Suzuki, and H. Matsuoka Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats Am. J. Hypertens. 21 2008 576 581
24. M. Brock, M. Trenkmann, R.E. Gay, B.A. Michel, S. Gay, M. Fischler, S. Ulrich, R. Speich, and L.C. Huber Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway Circ. Res. 104 2009 1184 1191
25. J. Wang, Y. Song, Y. Zhang, H. Xiao, Q. Sun, N. Hou, S. Guo, Y. Wang, K. Fan, D. Zhan, L. Zha, Y. Cao, Z. Li, X. Cheng, and X. Yang Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice Cell. Res. 22 2012 516 527
26. C. Jennewein, A. von Knethen, T. Schmid, and B. Brune MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization J. Biol. Chem. 285 2010 11846 11853
27. S. Sharma, X. Sun, R. Rafikov, S. Kumar, Y. Hou, P.E. Oishi, S.A. Datar, G. Raff, J.R. Fineman, and S.M. Black PPAR-gamma regulates carnitine homeostasis and mitochondrial function in a lamb model of increased pulmonary blood flow PLoS One 7 2012 e41555
28. S. Ameshima, H. Golpon, C.D. Cool, D. Chan, R.W. Vandivier, S.J. Gardai, M. Wick, R.A. Nemenoff, M.W. Geraci, and N.F. Voelkel Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth Circ. Res. 92 2003 1162 1169
29. R.E. Nisbet, R.L. Sutliff, and C.M. Hart The role of peroxisome proliferator-activated receptors in pulmonary vascular disease PPAR Res. 2007 2007 18797
30. R.E. Nisbet, J.M. Bland, D.J. Kleinhenz, P.O. Mitchell, E.R. Walp, R.L. Sutliff, and C.M. Hart Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model Am. J. Respir. Cell. Mol. Biol. 42 2010 482 490
31. M. Rabinovitch PPARgamma and the pathobiology of pulmonary arterial hypertension Adv. Exp. Med. Biol. 661 2010 447 458
32. D.S. Calnek, L. Mazzella, S. Roser, J. Roman, and C.M. Hart Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells Arterioscler. Thromb. Vasc. Biol. 23 2003 52 57
33. J.A. Polikandriotis, L.J. Mazzella, H.L. Rupnow, and C.M. Hart Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms Arterioscler. Thromb. Vasc. Biol. 25 2005 1810 1816
34. N. Sud, S. Sharma, D.A. Wiseman, C. Harmon, S. Kumar, R.C. Venema, J.R. Fineman, and S.M. Black Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90 Am. J. Physiol. Lung Cell. Mol. Physiol. 293 2007 L1444 L1453